BridgeBio Pharma ($BBIO) climbed 75% in a year as pipeline optimism fueled investor confidence

BridgeBio Pharma ($BBIO) shares have risen around 75% over the past year, driven by optimism around the company's advancing pipeline and reinforced by $1 billion in newly secured funding. Despite the strong rally, investors continue to assess whether the company's valuation fully reflects its long-term growth potential.